| Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis F De Benedetti, HI Brunner, N Ruperto, A Kenwright, S Wright, I Calvo, ... New England Journal of Medicine 367 (25), 2385-2395, 2012 | 962 | 2012 |
| 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of … A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ... Arthritis & rheumatology 68 (3), 566-576, 2016 | 881 | 2016 |
| Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis N Ruperto, HI Brunner, P Quartier, T Constantin, N Wulffraat, G Horneff, ... New England Journal of Medicine 367 (25), 2396-2406, 2012 | 808 | 2012 |
| Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosus HI Brunner, DD Gladman, D Ibañez, MD Urowitz, ED Silverman Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 612 | 2008 |
| Distinctions between diagnostic and classification criteria? R Aggarwal, S Ringold, D Khanna, T Neogi, SR Johnson, A Miller, ... Arthritis care & research 67 (7), 891, 2015 | 564 | 2015 |
| The diagnostic significance of soluble CD163 and soluble interleukin‐2 receptor α‐chain in macrophage activation syndrome and untreated new‐onset systemic juvenile idiopathic … J Bleesing, A Prada, DM Siegel, J Villanueva, J Olson, NT Ilowite, ... Arthritis & Rheumatism 56 (3), 965-971, 2007 | 374 | 2007 |
| Risk factors for damage in childhood‐onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage HI Brunner, ED Silverman, T To, C Bombardier, BM Feldman Arthritis & Rheumatism 46 (2), 436-444, 2002 | 362 | 2002 |
| Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis CA Wallace, EH Giannini, SJ Spalding, PJ Hashkes, KM O'Neil, AS Zeft, ... Arthritis & Rheumatism 64 (6), 2012-2021, 2012 | 354 | 2012 |
| Transancestral mapping and genetic load in systemic lupus erythematosus CD Langefeld, HC Ainsworth, DSC Graham, JA Kelly, ME Comeau, ... Nature communications 8 (1), 16021, 2017 | 348 | 2017 |
| Pediatric lupus—are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? R Mina, HI Brunner Rheumatic Disease Clinics 36 (1), 53-80, 2010 | 319 | 2010 |
| Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial HI Brunner, N Ruperto, Z Zuber, C Keane, O Harari, A Kenwright, P Lu, ... Annals of the rheumatic diseases 74 (6), 1110-1117, 2015 | 309 | 2015 |
| Urinary neutrophil gelatinase–associated lipocalin as a biomarker of nephritis in childhood‐onset systemic lupus erythematosus HI Brunner, M Mueller, C Rutherford, MH Passo, D Witte, A Grom, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 307 | 2006 |
| Sensitivity of the systemic lupus erythematosus disease activity index, British Isles lupus assessment group index, and systemic lupus activity measure in the evaluation of … HI Brunner, BM Feldman, C Bombardier, ED Silverman Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 248 | 1999 |
| International consensus on preliminary definitions of improvement in adult and juvenile myositis LG Rider, EH Giannini, HI Brunner, N Ruperto, L James‐Newton, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 240 | 2004 |
| Taxonomy for systemic lupus erythematosus with onset before adulthood CA Silva, T Avcin, HI Brunner Arthritis care & research 64 (12), 1787-1793, 2012 | 205 | 2012 |
| Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis M Suzuki, KM Wiers, MS Klein-Gitelman, KA Haines, J Olson, KB Onel, ... Pediatric Nephrology 23, 403-412, 2008 | 205 | 2008 |
| Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus R Mina, E Von Scheven, SP Ardoin, BA Eberhard, M Punaro, N Ilowite, ... Arthritis care & research 64 (3), 375-383, 2012 | 200 | 2012 |
| Neutrophil gelatinase–associated lipocalin is a predictor of the course of global and renal childhood‐onset systemic lupus erythematosus disease activity CH Hinze, M Suzuki, M Klein‐Gitelman, MH Passo, J Olson, NG Singer, ... Arthritis & Rheumatism 60 (9), 2772-2781, 2009 | 188 | 2009 |
| International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies CV Oddis, LG Rider, AM Reed, N Ruperto, HI Brunner, B Koneru, ... Arthritis & Rheumatism 52 (9), 2607-2615, 2005 | 186 | 2005 |
| 2021 DORIS definition of remission in SLE: final recommendations from an international task force RF van Vollenhoven, G Bertsias, A Doria, D Isenberg, E Morand, MA Petri, ... Lupus science & medicine 8 (1), e000538, 2021 | 181 | 2021 |
Lovell, D.J.在 cchmc.org 的电子邮件经过验证
